METHOD DEVELOPMENT AND VALIDATION OF UV-VISIBLE SPECTROSCOPIC METHOD FOR THE ESTIMATION OF ASSAY OF SUGAMMADEX SODIUM, APREMILAST, RIOCIGUAT AND VORAPAXAR SULFATE DRUGS IN API FORM.
Journal Title: Asian Journal of Pharamceutical and Clinical Research - Year 2017, Vol 10, Issue 2
Abstract
Objective: The objective of the present work is to develop a simple, efficient and reproducible spectrophotometric method for the quantitative estimation of Sugammadex Sodium, Apremilast, Riociguat and Vorapaxar sulfate drugs in its active pharmaceutical ingredient (API) form.Methods: The developed UV-Visible spectrophotometric method for the quantitative estimation of drugs – Sugammadex Sodium, Apremilast, Riociguat and Vorapaxar sulfate is based on measurement of absorption at a wavelength maximum (λmax) of 210nm, 230nm, 323nm and 271nm using water and methanol as diluents.Results: The method was validated in terms of specificity, precision, linearity, accuracy, and robustness as per the ICH guidelines. The method was found to be linear in the range of 33% to 167% for Sugammadex Sodium and Apremilast drug substances; 50% to 150% for Riociguat and Vorapaxar sulfate drug substances. The percentage recovery values were in the range of 99.7 to 100.9% for Sugammadex Sodium, 99.3 to 100.3% for Apremilast, 99.7 to 100.3% for Riociguat and in the range of 99.5 to 100.3% for Vorapaxar sulfate at different concentration levels. Relative standard deviation for precision and intermediate precision results were found to be less than 2%. The correlation co-efficient value observed for Sugammadex Sodium, Apremilast, Riociguat and Vorapaxar sulfate drug substances was not less than 0.99 for their respective drugs. Results obtained from the validation experiments prove that the developed method is quantified for the estimation of assay of Sugammadex Sodium, Apremilast, Riociguat and Vorapaxar sulfate drug substances.Conclusion: The developed method can be successfully applied for routine analysis, quality control analysis and also suitable for stability analysis of assay of Sugammadex Sodium, Apremilast, Riociguat and Vorapaxar sulfate in API form as per the regulatory requirements.Keywords: Sugammadex Sodium, Apremilast, Riociguat, Vorapaxar sulfate, Method Development, Validation, UV-Visible spectrophotometry.
Authors and Affiliations
V Ashok Chakravarthy, V Sailaja Bb, Praveen Kumar A
Keywords
Related Articles
- EP ID EP605443
- DOI 10.22159/ajpcr.2017.v10i2.15502
- Views 88
- Downloads 0
In vitro cytotoxic and apoptotic activity of polysaccharide rich Morinda citrofolia fruit on MCF-7 cells
Morinda citrofolia fruit or noni is well-known traditional medicine that has both antioxidant and anticancer activity. This study was designed toinvestigate experimentally the anti-apoptotic effect of polysaccharide isol...
IN VITRO ANALYSIS: THE ANTIMICROBIAL AND ANTIOXIDANT ACTIVITY OF ZINC OXIDE NANOPARTICLES FROM CURCUMA LONGA
Objective: Curcuma longa is a known natural medicine for inflammation from ancient times. It has a low absorption rate and poor solubility. Hence, it is used for the green synthesis of nanoparticles. Zinc oxide nanoparti...
MIMOSINE - A NOVEL SUBSTANCE AND EVALUATE THE LIPID PEROXIDATION
Objective: The mimosine is a novel substance extracted and purified from Mimosa pudica. The present study is to evaluate lipid peroxidation (LPO). Methods: The sox halation is used to differentiate extracts. Mimosine is...
A REVIEW ON THE SYNTHETIC METHODOLOGIES OF CHROMONES
Chromones group of compounds and their derivatives form the essential component of pharmacophores in many biologically active molecules. They exhibit a wide range of biological activities such as antibiotic, antitumor, a...
OPTIMIZATION AND EVALUATION OF CHLORPHENIRAMINE MALEATE ORAL STRIP FOR PEDIATRIC USE
Objective: The goal of performing this study is to prepare an oral strip, especially designed for pediatric use that provides fast onset of action with ease of swallowing particularly for young individuals who suffer fro...